248 related articles for article (PubMed ID: 16901183)
21. Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options.
Neri L; Miracapillo A
G Ital Dermatol Venereol; 2015 Feb; 150(1):19-26. PubMed ID: 25521808
[TBL] [Abstract][Full Text] [Related]
22. Electronic monitoring in medication adherence measurement. Implications for dermatology.
Koehler AM; Maibach HI
Am J Clin Dermatol; 2001; 2(1):7-12. PubMed ID: 11702622
[TBL] [Abstract][Full Text] [Related]
23. Assessment of "corticophobia" as an indicator of non-adherence to topical corticosteroids: A pilot study.
Mueller SM; Itin P; Vogt DR; Walter M; Lang U; Griffin LL; Euler S
J Dermatolog Treat; 2017 Mar; 28(2):104-111. PubMed ID: 27396480
[TBL] [Abstract][Full Text] [Related]
24. Dermatologic treatment during pregnancy: practical overview.
Al Hammadi A; Al-Haddab M; Sasseville D
J Cutan Med Surg; 2006; 10(4):183-92. PubMed ID: 17234117
[TBL] [Abstract][Full Text] [Related]
25. Vehicles Always Matter.
Kircik LH
J Drugs Dermatol; 2019 Feb; 18(2s):s99. PubMed ID: 30811152
[TBL] [Abstract][Full Text] [Related]
26. Prescription-level factors associated with primary nonadherence to dermatologic medications.
Rutherford A; Glass DA; Suarez EA; Adamson AS
J Dermatolog Treat; 2018 May; 29(3):300-304. PubMed ID: 28783420
[TBL] [Abstract][Full Text] [Related]
27. Health behaviour models: a framework for studying adherence in children with atopic dermatitis.
Chisolm SS; Taylor SL; Gryzwacz JG; O'Neill JL; Balkrishnan RR; Feldman SR
Clin Exp Dermatol; 2010 Apr; 35(3):228-32. PubMed ID: 19886956
[TBL] [Abstract][Full Text] [Related]
28. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation.
Butler DC; Heller MM; Murase JE
J Am Acad Dermatol; 2014 Mar; 70(3):417.e1-10; quiz 427. PubMed ID: 24528912
[TBL] [Abstract][Full Text] [Related]
29. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
Kircik LH
J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882
[TBL] [Abstract][Full Text] [Related]
30. [Adherence to treatment in chronic skin disorders].
Chastaing M; Misery L; Schollhammer M
Rev Med Interne; 2011 May; 32(5):314-8. PubMed ID: 21056520
[TBL] [Abstract][Full Text] [Related]
31. Navigating Targeted Therapeutics in Dermatology: Biologics and Small Molecules.
Costello C; Maarouf M; Shi V
J Drugs Dermatol; 2018 Dec; 17(12):1330-1332. PubMed ID: 30586268
[TBL] [Abstract][Full Text] [Related]
32. [Future of topical therapy].
Wohlrab J; Staubach P
Hautarzt; 2014 Mar; 65(3):168. PubMed ID: 24622850
[No Abstract] [Full Text] [Related]
33. Objective assessment of compliance with psoriasis treatment.
Zaghloul SS; Goodfield MJ
Arch Dermatol; 2004 Apr; 140(4):408-14. PubMed ID: 15096368
[TBL] [Abstract][Full Text] [Related]
34. Use of calcium channel blockers in dermatology: a narrative review.
Lo Y; Lin LY; Tsai TF
Expert Rev Clin Pharmacol; 2021 Apr; 14(4):481-489. PubMed ID: 33612036
[No Abstract] [Full Text] [Related]
35. Effect of quality of life impact and clinical severity on adherence to topical acne treatment.
Tan JK; Balagurusamy M; Fung K; Gupta AK; Thomas DR; Sapra S; Lynde C; Poulin Y; Gulliver W; Sebaldt RJ
J Cutan Med Surg; 2009; 13(4):204-8. PubMed ID: 19706228
[TBL] [Abstract][Full Text] [Related]
36. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring.
Alinia H; Moradi Tuchayi S; Smith JA; Richardson IM; Bahrami N; Jaros SC; Sandoval LF; Farhangian ME; Anderson KL; Huang KE; Feldman SR
Br J Dermatol; 2017 Mar; 176(3):759-764. PubMed ID: 27664969
[TBL] [Abstract][Full Text] [Related]
37. [What's new in pediatric dermatology?].
Stalder JF
Ann Dermatol Venereol; 2007 Dec; 134 Suppl 1():8S36-52. PubMed ID: 18675140
[TBL] [Abstract][Full Text] [Related]
38. Tazarotene foam, 0.1%, for the treatment of acne.
Smith JA; Narahari S; Hill D; Feldman SR
Expert Opin Drug Saf; 2016 Jan; 15(1):99-103. PubMed ID: 26560170
[TBL] [Abstract][Full Text] [Related]
39. Pilot randomized-control trial to assess the effect product sampling has on adherence using adapalene/benzoyl peroxide gel in acne patients.
Sandoval LF; Semble A; Gustafson CJ; Huang KE; Levender MM; Feldman SR
J Drugs Dermatol; 2014 Feb; 13(2):135-40. PubMed ID: 24509962
[TBL] [Abstract][Full Text] [Related]
40. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP).
Reich K; Zschocke I; Bachelez H; de Jong EMGJ; Gisondi P; Puig L; Warren RB; Ortland C; Mrowietz U;
Br J Dermatol; 2017 Jul; 177(1):197-205. PubMed ID: 28301043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
